Page last updated: 2024-08-16

triazolam and cardiovascular agents

triazolam has been researched along with cardiovascular agents in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Neuvonen, PJ; Olkkola, KT; Varhe, A	1

Trials

1 trial(s) available for triazolam and cardiovascular agents

Article	Year
Diltiazem enhances the effects of triazolam by inhibiting its metabolism. Clinical pharmacology and therapeutics, 1996, Volume: 59, Issue:4 Topics: Administration, Oral; Adult; Cardiovascular Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Female; Half-Life; Humans; Hypnotics and Sedatives; Male; Mixed Function Oxygenases; Reference Values; Triazolam	1996

Article

Year

Diltiazem enhances the effects of triazolam by inhibiting its metabolism.

Clinical pharmacology and therapeutics, 1996, Volume: 59, Issue:4

Topics: Administration, Oral; Adult; Cardiovascular Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Female; Half-Life; Humans; Hypnotics and Sedatives; Male; Mixed Function Oxygenases; Reference Values; Triazolam

1996